Efficacy of Upadacitinib in Treating Atopic Dermatitis in Sensitive Regions: Outcomes from a Multicenter Real-World Study on Hand, Head/Neck, and Genital Involvement

1

Upadacitinib demonstrated rapid and sustained improvement in atopic dermatitis affecting sensitive areas like hands, head/neck, and genital regions.
2

The study included 57 patients with moderate-to-severe atopic dermatitis, focusing on those with special area involvement.
3

Clinically meaningful responses to upadacitinib were observed even in patients with prior biologic exposure and mixed eczema–psoriasis phenotypes.
4

Broad JAK1 inhibition may effectively address the complex inflammatory pathways present in anatomically sensitive areas.
5

Findings support upadacitinib as a viable treatment option for patients with significant disease burden in special or sensitive sites.

Dermatology And Therapy (Springer)

by Francisco Javier Melgosa Ramos, Santiago Guillén-Climent, Raquel Cavestany Rodriguez, Javier Sabater-Abad, Antonio Martorell, Fátima Tous Romero
February 22, 2026

1